Navigation Links
FluoroPharma Announces $1.6M Capital Raise
Date:6/23/2011

BOSTON, June 23, 2011 /PRNewswire/ -- FluoroPharma Medical (OTC.BB: FPMI) announced it has received subscriptions from select accredited investors for gross proceeds of $1.6 million in a private placement offering. The proceeds from this financing together with the previously announced financing in May 2011 aggregates $5.3 million. The Company intends to use the proceeds of the offering for working capital purposes.

"We are pleased that we can continue to fund the advancement of our portfolio of compounds," said Thijs Spoor, FluoroPharma's Chief Executive Officer. "This step will allow the company to significantly advance its clinical development."  Dr. David Elmaleh, Chairman of the Board of Directors and the inventor of the technology added, "the company has previously reached significant milestones and we expect to continue to focus our efforts on executing FluoroPharma's strategic plan."

Noble Capital Markets acted as placement agent and Sichenzia Ross Friedman and Ference acted as counsel on the transaction.

The securities offered in this financing transaction have not been registered under the Securities Act of 1933, as amended (the "Securities Act"), or applicable state securities laws. Accordingly, the securities may not be offered or sold in the United States except pursuant to an effective registration statement or an applicable exemption from the registration requirements of the Securities Act and such applicable state securities laws. The securities were offered only to qualified accredited investors. The Company has agreed to file a registration statement with the Securities and Exchange Commission registering the resale of the shares and the shares of common stock issuable upon exercise of the warrants. Any offering of the Company's securities under the resale registration statement referred to above will be made only by means of a prospectus.

This release does not constitute an offer to sell or the solicitation of
'/>"/>

SOURCE FluoroPharma Medical
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. FluoroPharma Announces Completion of Merger and Fund Raising
2. FluoroPharma, Inc. to Report Preclinical Data on Alzheimers Disease and Prostate Cancer PET Imaging Agents
3. FluoroPharma Announces Positive Phase I Safety Results for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET)
4. FluoroPharma Announces Commencement of Phase I Clinical Trial for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET)
5. FluoroPharma Announces Positive Phase I Safety Results for CardioPET(TM), Coronary Artery Disease (CAD) Imaging Tracer for Positron Emission Tomography (PET)
6. Akorn, Inc. Announces Second Quarter 2011 Earnings Release and Conference Call Information
7. Merriman Capital Announces Sponsorship of Radient Pharmaceuticals Corporation on OTCQX
8. ULURU Inc. Announces the Engagement of Gilford Securities Incorporated to Serve as the Companys Financial Advisor
9. Centrix Pharmaceutical, Inc. Announces Agreement With CutisPharma, Inc. to Promote FIRSTĀ® - Progesterone VGS Compounding Kit
10. MacroGenics Announces Presentation of Protege Phase 3 Clinical Data at ADA in San Diego on June 28
11. Watson Announces Expansion of Salt Lake City, Utah Pharmaceutical R&D and Manufacturing Facility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... RAPIDS, Mich. , Jan. 15, 2014 As health ... the flu virus, select Meijer pharmacies in Michigan ... strep throat to eligible patients, enabling Meijer pharmacists to administer ... strict protocol set by a physician participating in the study. ...
(Date:1/15/2014)... Jan. 15, 2014  Celsion Corporation (the "Company") (NASDAQ: ... from institutional investors to purchase an aggregate of approximately ... at-the-market registered direct offering, led by a dedicated health ... purchase agreements with these investors pursuant to which the ...
(Date:1/15/2014)... Jan. 15, 2014  Humberto C. Antunes,  Galderma  worldwide CEO, ... the Journal of Drugs in Dermatology (JDD) ... (ODAC). The event is January 17-20, 2014, at the Omni Orlando ... The ODAC is a distinguished event ...
Breaking Medicine Technology:Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 2Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 3Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4
... , April 22 Ampio Pharmaceuticals, Inc. (OTC Bulletin Board: ... (LOI) to acquire DMI Biosciences, Inc. , ... This acquisition will give AMPIO access to all rights, royalties ... licensed to a specialty pharmaceutical company after demonstrating safety and efficacy in ...
... ,, HARBIN, China , ... ("Renhuang" or the "Company"), a,developer, manufacturer and distributor of botanical ... has significantly reduced its Days Sales Outstanding ("DSO"),resulting in improved ... , , ...
Cached Medicine Technology:Ampio Pharmaceuticals to Acquire DMI Biosciences, Inc. 2Ampio Pharmaceuticals to Acquire DMI Biosciences, Inc. 3Renhuang Pharmaceuticals Announces Continual Improvement in Days Sales Outstanding 2Renhuang Pharmaceuticals Announces Continual Improvement in Days Sales Outstanding 3Renhuang Pharmaceuticals Announces Continual Improvement in Days Sales Outstanding 4
(Date:4/17/2014)... in PLOS Pathogens , children who live in ... mount an immune response to infection with malaria parasites ... high fever and illness and partially control the growth ... help researchers develop future interventions that prevent or mitigate ... year, approximately 200 million cases of malaria occur worldwide, ...
(Date:4/17/2014)... MANHASSET, NY In a review published in the ... MD, president of The Feinstein Institute for Medical Research, ... the medical community,s approach to treating sepsis, ... 200,000 Americans. , Sepsis occurs when molecules released into ... inflammation throughout the body. Inflammation is necessary for maintaining ...
(Date:4/17/2014)... Doctors who treat patients with a severe ... face an agonizing treatment decision. , The drug ... help relieve shortness of breath. But some patients ... cause potentially fatal complications following transplantation. , "It,s ... medical director of Loyola University Medical Center,s LAM ...
(Date:4/17/2014)... By discovering a new mechanism that allows blood ... at UC Irvine and the Salk Institute have opened ... prevent stroke-induced brain damage. , A complex and devastating ... and primary reason for disability in the U.S. The ... lets blood-borne material into the brain, causing the permanent ...
(Date:4/17/2014)... online has the potential to ward off depression among ... research published online in The Journals of ... . In the article " Internet Use and Depression ... Longitudinal Analysis ," the authors report that Internet use ... percent among their study sample. , Late-life depression ...
Breaking Medicine News(10 mins):Health News:Study sheds light on how the immune system protects children from malaria 2Health News:Feinstein Institute researcher publishes new perspective on sepsis 2Health News:Patients with rare lung disease face agonizing treatment dilemma 2Health News:Patients with rare lung disease face agonizing treatment dilemma 3Health News:Study IDs new cause of brain bleeding immediately after stroke 2Health News:Internet use may cut retirees' depression 2
... Annapolis Media ... Event, ANNAPOLIS, Md., Sept. ... will have used,an inhalant by the 8th grade. In Maryland, inhalant use is ... are,the drug of choice, with use rates over twice the rate of marijuana ...
... 28 With audience members cheering and,famous Chicago chefs ... cooker for the finalists at Consorta,s Battle of the ... as the organic cucumbers he,serves the patients at Saint ... the event,s Gold Chef Award, becoming the reigning champion ...
... "Tonight the candidates,lost an opportunity to engage in ... dominate people,s day to day lives. (Logo: ... in the African American,community, with one in four adults ... able to afford to retire. "With just one ...
... has recently inspired research into its therapeutic value ... prevention. A painful, progressive autoimmune disease, rheumatoid ... of depressiondouble the risk of the healthy population, ... Increasingly, RA patients are turning to alternative ...
... raised in bilingual homes learned two similar-sounding words in a ... raised in homes where only one language is spoken. This ... appears to be due to the fact that bilingual babies ... words and objects (often a word in each language) for ...
... In a victory for the,families of small business ... legislation that will improve accessibility of the State,Children,s ... and Olympia Snowe (R-Maine) attached an amendment to ... to enroll more,children in the program. The provision ...
Cached Medicine News:Health News:National Battle of the Hospital Chefs Cooks Up a Winner 2Health News:Post-Debate Statement from AARP Board Member Joyce Payne 2Health News:Meditation therapy for rheumatoid arthritis patients 2Health News:Meditation therapy for rheumatoid arthritis patients 3Health News:Babies raised in bilingual homes learn new words differently than infants learning one language 2Health News:Babies raised in bilingual homes learn new words differently than infants learning one language 3Health News:Bipartisan Bill Expands Health Care Access for Small Businesses 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: